黄金城集团

概览

黄金城集团致力于为全球科研机构提供新冠病毒(SARS-CoV-2, COVID-19)研究级多肽。

针对热门靶点,黄金城集团专家团队参考现有文献,以丰富的经验设计了多种新冠病毒相关多肽为您全方位提供支持,您可以根据需求选择多肽合成多肽文库*、或肽池等交付形式,用于免疫学等研究。

更多信息,请联系黄金城集团专业技术支持团队peptide@nrapc.com

产品详情


***参考文献
1. Lee, Chloe Hyun-Jung, and Hashem Koohy. "In silico identification of vaccine targets for 2019-nCoV." F1000Research 9 (2020).
2. Grifoni, Alba, et al. "A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe (2020).
3. Cheung, Y. K., et al. "Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection." Hong Kong medical journal= Xianggang yi xue za zhi 14 (2008): 27-30.
4. Wan Y, Shang J, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020 Mar 17;94(7).
5. Chen Y, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 Feb 17.
6. Vickers, C. et al. J. Biol. Chem. 277, 14838 (2002).
7. Huang, L. et al. J. Biol. Chem. 278, 15532 (2003).

多肽服务类型

询价与订购

订购信息

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*